Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $423000.0.

  • Camp4 Therapeutics' Interest & Investment Income rose 35000.0% to $423000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 6089.99%. This contributed to the annual value of $1.3 million for FY2024, which is 5263.53% down from last year.
  • Latest data reveals that Camp4 Therapeutics reported Interest & Investment Income of $423000.0 as of Q3 2025, which was up 35000.0% from $453000.0 recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Interest & Investment Income registered a high of $689000.0 during Q3 2023, and its lowest value of $94000.0 during Q3 2024.
  • Over the past 3 years, Camp4 Therapeutics' median Interest & Investment Income value was $453000.0 (recorded in 2025), while the average stood at $450222.2.
  • Per our database at Business Quant, Camp4 Therapeutics' Interest & Investment Income tumbled by 8635.7% in 2024 and then soared by 35000.0% in 2025.
  • Quarter analysis of 3 years shows Camp4 Therapeutics' Interest & Investment Income stood at $569000.0 in 2023, then rose by 7.21% to $610000.0 in 2024, then plummeted by 30.66% to $423000.0 in 2025.
  • Its Interest & Investment Income was $423000.0 in Q3 2025, compared to $453000.0 in Q2 2025 and $588000.0 in Q1 2025.